Koers MetaStat, Inc. Other OTC
Aandelen
MTST
US59140A2033
Biotechnologie & Medisch Onderzoek
Omzet 2017 | - | Omzet 2018 | 0,02 0,02 | Marktkapitalisatie | 6,98 mln. 6,49 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -2 mln. -1,86 mln. | Nettowinst (verlies) 2018 | -3 mln. -2,79 mln. | EV/omzet 2017 | - |
Nettoschuld 2017 | 206K 192K | Nettoschuld 2018 | 683K 635K | EV/omzet 2018 | 329.023.519 x |
K/w-verhouding 2017 |
-0,72
x | K/w-verhouding 2018 |
-2,02
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 98,43% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-08-14 | |
Frederick Pierce
IRC | Investor Relations Contact | 63 | 01-03-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-08-14 | |
Paul Billings
BRD | Director/Board Member | 71 | 24-05-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,9 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |